Disc Medicine IRON Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $45.9M+65.3% | $46.22M+86.4% | $50.33M+104% | $46.32M+97.2% | $27.76M+17.1% | ||
| $23.62M+93.9% | $20.75M+113% | $17.36M+112% | $15.09M+105% | $12.18M+57.0% | ||
| $69.52M+74.0% | $66.97M+93.8% | $67.7M+106% | $61.41M+99.0% | $39.95M+27.0% | ||
| $69.52M+74.0% | $66.97M+93.8% | $67.7M+106% | $61.41M+99.0% | $39.95M+27.0% | ||
| $844K-5.9% | $883K+54.4% | $917K— | $910K— | $897K— | ||
| $6.07M+1.5% | $6.53M+23.9% | $5.48M-14.0% | $6.22M+36.3% | $5.98M+32.4% | ||
| $51K-57.1% | $88K-50.0% | $102K-10.5% | $52K-13.3% | $119K+2,280% | ||
| -$63.5M-86.3% | -$60.53M-105% | -$62.32M-134% | -$55.25M-110% | -$34.09M-26.5% | ||
| -$1.65-61.8% | -$1.62-65.3% | -$1.77-98.9% | -$1.58-53.4% | -$1.02+6.4% | ||
| -$1.65-61.8% | -$1.62-65.3% | -$1.77-98.9% | -$1.58-53.4% | -$1.02+6.4% | ||
| 38.5M+15.5% | 35.3M+27.9% | 35.2M+17.5% | 35M+36.6% | 33.3M+34.3% | ||
| 38.5M+15.5% | 35.3M+27.9% | 35.2M+17.5% | 35M+36.6% | 33.3M+34.3% | ||
| -$65.04M-92.2% | -$60.28M-102% | -$61.88M-140% | -$55.51M-110% | -$33.84M-25.6% | ||
| $2.74M+315% | $1.75M— | $918K+188% | -$321K+52.0% | -$1.28M+82.6% | ||
| $1.7M-99.3% | $216.68M+652% | $11.59M+2,620% | $892K-99.5% | $244.25M+1,436% | ||
| $58.31M+121% | -$222.89M-15,531% | —— | —— | -$272.63M-406,815% | ||
| -$62.24M-50.4% | -$43.3M-57.0% | -$47.8M-175% | -$47.92M-211% | -$41.38M-23.1% | ||
| -$1.53M-758% | $247K— | $445K-47.6% | -$247K-274% | $232K— | ||
| -$10K-171% | $0— | $0+100% | -$15K-350% | $14K— | ||
| $22K+833% | $0— | -$18K-300% | $68K+623% | -$3K-200% | ||
| -$69.44M-73.9% | -$66.88M-93.6% | -$67.61M-106% | -$61.33M-99.5% | -$39.93M-27.0% | ||
| -$69.52M-74.0% | -$66.97M-93.8% | -$67.7M-106% | -$61.41M-99.0% | -$39.95M-27.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Disc Medicine profitable?
- Disc Medicine is not currently profitable: it reported a net loss of $241.6M over the trailing twelve months.
- What is Disc Medicine's earnings per share?
- Disc Medicine's diluted EPS over the trailing twelve months is $-6.62.
- Where does Disc Medicine's income statement data come from?
- Every line is extracted from Disc Medicine's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.